Urinary tract infections in infants: comparison between those with conjugated vs unconjugated hyperbilirubinaemia

Hung-Chang Lee1, Shiuh-Bin Fang, Chun-Yan Yeung

  • 1Department of Paediatrics, Mackay Memorial Hospital, Taiwan; Department of Paediatrics, Taipei Medical Uinversity, Taiwan.

Insights

In young infants with urinary tract infections (UTI), unconjugated hyperbilirubinaemia can occur early. After six weeks, conjugated hyperbilirubinaemia is common, often linked to anemia and liver enzyme elevation.

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Infectious Diseases

Background:

  • Prolonged jaundice in infants can be a sign of underlying conditions.
  • Urinary tract infections (UTI) are common in young infants and can present with jaundice.

Purpose of the Study:

  • To investigate the association between conjugated and unconjugated hyperbilirubinaemia and urinary tract infections (UTI) in young infants.
  • To differentiate clinical characteristics of infants with conjugated versus unconjugated hyperbilirubinaemia in the context of UTI.

Main Methods:

  • Retrospective analysis of 50 infants (<3 months) with prolonged jaundice and UTI from 1984-2004.
  • Categorization into conjugated (n=22) and unconjugated (n=28) hyperbilirubinaemia groups.
  • Comparison of clinical variables including hemoglobin, liver enzymes, age, jaundice duration, and causative pathogens.

Main Results:

  • Conjugated hyperbilirubinaemia group showed lower hemoglobin, higher AST/ALT, older age at admission, and longer jaundice duration.
  • Escherichia coli (E. coli) infections were more frequent in the conjugated group (19/22 vs 15/28).
  • Direct/total bilirubin ratio correlated with jaundice duration; jaundice >38 days suggested conjugated type, and >44 days made unconjugated type unlikely.

Conclusions:

  • Young infants with UTI can present with unconjugated hyperbilirubinaemia early on.
  • After six weeks of age, jaundice in infants with UTI is typically conjugated.
  • Conjugated hyperbilirubinaemia in this cohort was frequently associated with anemia, elevated hepatic aminotransferases, and E. coli infections.
Abstract

Related Concept Videos

Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...